secwatch.observer — SEC 8-K summary
======================================

Issuer:     USANA HEALTH SCIENCES INC (USNA)
CIK:        0000896264
Form:       8-K
Filed at:   2023-04-25T23:59:59+00:00
Accession:  0001157523-23-000608
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

USANA Q1 net sales $248M, EPS $0.95; raises FY23 guidance low end
-----------------------------------------------------------------

- Net sales $248M, +9% sequentially but -9% YoY; diluted EPS $0.95 (+44% sequentially, -17% YoY).
- FY2023 guidance raised: net sales $875-$950M (previously $850-$950M), EPS $2.40-$3.30 (prev $2.35-$3.30).
- Active customers 491,000, flat sequentially, -11% YoY; Asia Pacific net sales $200M (80% of total).
- Q1 included ~$12M China COVID-demand benefit and ~$13M price-increase pull-forward; new market expansion planned.
- Ended quarter with $295M cash, debt-free; no share repurchases; $83M remaining under authorization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896264/000115752323000608/0001157523-23-000608-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896264/000115752323000608/a53387511.htm
  HTML page:      https://secwatch.observer/filing/0001157523-23-000608

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer